Abstract
Novel titanium oxide (TiO2) nanoparticles were fabricated via a modified propanol drying step. These nanoparticles were loaded with anti-cancer drug paclitaxel (PTX) to yield PTX-TiO2 nanocomposites. The nanocomposites were characterized for their size and surface morphology employing nanoparticle tracking analysis (NTA) and scanning electron microscopy (SEM). The SEM images showed spherical particles with smooth surface and narrow size distribution of ~30–40 nm, which was also supported by NTA analysis data. The drug loading efficiency of the air-dried nanoparticles was observed to be ~63.61 % while those prepared through propanol-induced drying step showed ~69.70 %, thereby demonstrating higher efficiency of the latter. In vitro pH-dependent release of the loaded PTX was observed with higher release at acidic pH compared with physiological pH. Cell uptake studies suggested of time-dependent internalization of nanocomposites with significant improvement in uptake by increasing incubation time from 2 to 24 h, as evidenced by flow cytometry. Further, the cell viability as a measure of anti-cancer activity revealed that cell viability upon exposure to PTX only was 40.5 % while that of PTX-TiO2 nanocomposite showed 21.6 % viability after 24 h, suggesting better anti-cancer efficacy of nanocomposites. Apoptosis studies revealed that cells treated with PTX-TiO2 nanocomposites possessed more amount of apoptotic bodies as compared to those treated with PTX only.
Similar content being viewed by others
References
Bhattacharyya S, Kudgus RA, Bhattacharya R, Mukherjee P (2011) Inorganic nanoparticles in cancer therapy. Pharm Res 28:237–259. doi:10.1007/s11095-010-0318-0
Chen Y, Zheng X, Qian H, Mao Z, Ding D, Jiang X (2010) Hollow core-porous shell structure poly(acrylic acid) nanogels with a superhigh capacity of drug loading. ACS Appl Mater Interfaces 2:3532–3538. doi:10.1021/am100709d
Cho EC, Zhang Q, Xia Y (2011) The effect of sedimentation and diffusion on cellular uptake of gold nanoparticles. Nat Nanotechnol 6:385–391. doi:10.1038/nnano.2011.58
Constantine GD, Pickar JH (2003) Estrogens in postmenopausal women: recent insights. Curr Opin Pharmacol 3:626–634. doi:10.1016/j.coph.2003.07.003
Eisenhauer EA, Vermorken JB (1998) The taxoids. Comparative clinical pharmacology and therapeutic potential. Drugs 55:5–30
Emerich DF, Thanos CG (2007) Targeted nanoparticle-based drug delivery and diagnosis. J Drug Target 15:163–183. doi:10.1080/10611860701231810
Fan W (1999) Possible mechanism of paclitaxel-induced apoptosis. Biochem Pharmacol 57:1215–1221. doi:10.1016/S0006-2952(99)00006-4
Hankinson S, Colditz G, Willett W (2004) Towards an integrated model for breast cancer etiology: the lifelong interplay of genes, lifestyle, and hormones. Breast Cancer Res 6:1–6. doi:10.1186/bcr921
Jemal A et al (2005) Cancer Statistics, 2005. CA Cancer J Clin 55:10–30. doi:10.3322/canjclin.55.1.10
Jiang W, KimBetty YS, Rutka JT, ChanWarren CW (2008) Nanoparticle-mediated cellular response is size-dependent. Nat Nanotechnol 3:145–150 doi:http://www.nature.com/nnano/journal/v3/n3/suppinfo/nnano.2008.30_S1.html
Jordan MA, Wilson L (1998) Chapter 15 the use and action of drugs in analyzing mitosis. In: Conly LR (ed) Methods in cell biology, vol 61. Academic Press, New York, pp 267–295. doi:10.1016/S0091-679X(08)61986-X
Kocbek P, Teskac K, Kreft ME, Kristl J (2010) Toxicological aspects of long-term treatment of keratinocytes with ZnO and TiO2 nanoparticles. Small 6:1908–1917. doi:10.1002/smll.201000032
Kolen’ko YV, Burukhin AA, Churagulov BR, Oleynikov NN (2003) Synthesis of nanocrystalline TiO2 powders from aqueous TiOSO4 solutions under hydrothermal conditions. Mater Lett 57:1124–1129
Kunjachan S et al (2012) Overcoming cellular multidrug resistance using classical nanomedicine formulations. Eur J Pharm Sci 45:421–428. doi:10.1016/j.ejps.2011.08.028
Lammel AS, Hu X, Park SH, Kaplan DL, Scheibel TR (2010) Controlling silk fibroin particle features for drug delivery. Biomaterials 31:4583–4591. doi:10.1016/j.biomaterials.2010.02.024
Matsumura Y, Maeda H (1986) A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 46:6387–6392
Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65(1–2):55–63. doi:10.1016/0022-1759(83)90303-4
Prabaharan M, Grailer JJ, Pilla S, Steeber DA, Gong S (2009) Amphiphilic multi-arm-block copolymer conjugated with doxorubicin via pH-sensitive hydrazone bond for tumor-targeted drug delivery. Biomaterials 30:5757–5766. doi:10.1016/j.biomaterials.2009.07.020
Schmaljohann D (2006) Thermo- and pH-responsive polymers in drug delivery. Adv Drug Deliv Rev 58:1655–1670. doi:10.1016/j.addr.2006.09.020
Seo J, Dembereldorj U, Park J, Kim M, Kim S, Joo S-W (2012) Facile internalization of paclitaxel on titania nanoparticles in human lung carcinoma cells after adsorption of serum proteins. J Nanopart Res 14:1–8. doi:10.1007/s11051-012-1164-2
Syres K, Thomas A, Bondino F, Malvestuto M, Gratzel M (2010) Dopamine adsorption on anatase TiO2(101): a photoemission and NEXAFS spectroscopy study. Langmuir 26:14548–14555. doi:10.1021/la1016092
Vamanu CI, Cimpan MR, Hol PJ, Sornes S, Lie SA, Gjerdet NR (2008) Induction of cell death by TiO2 nanoparticles: studies on a human monoblastoid cell line. Toxicol In Vitro 22:1689–1696. doi:10.1016/j.tiv.2008.07.002
Verwey EJW, Overbeek JTG, Van Nes K (1948) Theory of the stability of lyophobic colloids: the interaction of sol particles having an electric double layer. Elsevier, New York
Yoo HS, Lee KH, Oh JE, Park TG (2000) In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin-PLGA conjugates. J Control Release 68:419–431
Zhang H, Jiang H, Wang H, Zhao J, Chen B, Wang X (2011) Ultrasound mediated drug-loaded nanoparticles crossing cell membranes as a new strategy to reverse cancer multidrug resistance. J Nanosci Nanotechnol 11:1834–1840
Zhang H, Wang C, Chen B, Wang X (2012) Daunorubicin-TiO2 nanocomposites as a “smart” pH-responsive drug delivery system. Int J Nanomedicine 7:235–242. doi:10.2147/IJN.S27722
Acknowledgments
The authors highly appreciate the support of Director of NIT, Rourkela for funding and Mr L. B. Sukla, Chief Scientist IMMT, Bhubaneswar for providing the lab facility to carry out certain portion of the research work.
Conflict of interest
The authors hereby declare no conflict of interest in this work.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mund, R., Panda, N., Nimesh, S. et al. Novel titanium oxide nanoparticles for effective delivery of paclitaxel to human breast cancer cells. J Nanopart Res 16, 2739 (2014). https://doi.org/10.1007/s11051-014-2739-x
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11051-014-2739-x